NRAS Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers Premium The findings should spur cancer centers to review testing rates and address barriers, said experts from Hackensack University, Cota Healthcare, and Guardant Health. TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Keytruda and Ibrance demonstrate activity in molecularly defined populations, while a new cohort will explore Gilotrif in tumors with NRG1 fusions. Lung Cancer Panel From PlexBio Receives CE Mark The assay can identify KRAS, NRAS, PIK3CA, BRAF, and EGFR gene mutations, as well as 19 gene rearrangements of the ALK, ROS1, RET, NTRK1, and MET genes from FFPE. Biocartis Gets CE Mark for Idylla NRAS-BRAF Mutation Test The combination of the new test with Biocartis' existing KRAS assay offers customers a complete solution for testing metastatic colorectal cancers as reccomended by professional guidelines. Qiagen Inks Master CDx Collaboration With Array BioPharma One of the first projects between the firms will be to develop and commercialize a companion diagnostic for the MEK inhibitor binimetinib in NRAS-mutant melanoma. Mar 30, 2015 CAP, AMP Among Groups Jointly Issuing Colorectal Cancer Molecular Testing Draft Recommendations May 28, 2014 With New Indication for Vectibix, FDA Approves Qiagen's Therascreen KRAS Test as Companion Diagnostic Premium Apr 2, 2014 In Head-to-Head Comparison, Vectibix Bests Avastin in mCRC Patients with Wild-type RAS Tumors Premium Jan 30, 2014 Product Watch: EntroGen KRAS, NRAS Mutation Analysis Kits Premium May 15, 2013 Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients Premium Jul 26, 2012 Dx Focus: Cepheid Updates Xpert BCR-ABL Assay; CBLPath Offers NRAS Mutation Test Premium Apr 21, 2010 Competing Pharmas Race to Pinpoint Markers Beyond KRAS for Personalized Colorectal Cancer Rx Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.